Welcome to SynapCell
SynapCell is a preclinical Contract Research Organization which provides translational solutions to evaluate the therapeutic potential of CNS drug candidates in epilepsy. SynapCell provides customized solutions which cover the entire range of customers needs, from early steps to the final answer.
Meet SynapCell at AES annual meeting in Washington,D.C.
Join us to our poster session at AES annual meeting, Washington D.C.
SynapCell provides innovative and translational drug discovery solutions in CNS using integrated electrophysiology.
In epilespy, we became your expert partner in assessing the efficacy of your drug candidates through predictive animal models of chronic epilepsy with protocols mimicking clinical trials and quantitative results using EEG and qEEG.
Therefore, SynapCell will attend the AES annual meeting that will take place in Washington, D.C. from December 6th to 10th, 2013.
We will be presenting the work of SynapCell’s team on EEG profiling of the most commounly used AEDs in our MTLE mouse during the poster session 1 on December 7th (poster #1.211).
We will be happy to meet you there!
Feel free to contact us